Stock SOLV SOLVENTUM CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Solventum Corporation

Equities

SOLV

US83444M1018

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 01:30:02 25/05/2024 am IST 		5-day change 1st Jan Change
60.45 USD +0.87% Intraday chart for Solventum Corporation -1.80% 0.00%
09/05 Solventum Q1 Adjusted Earnings Decline, Net Sales Increase MT
09/05 Earnings Flash (SOLV) SOLVENTUM Posts Q1 Revenue $2.02B MT

Valuation

Fiscal Period: December 2024 2025 2026
Capitalization 1 10,440 - -
Enterprise Value (EV) 1 17,442 16,913 15,994
P/E ratio 15.8 x 15.2 x 11.9 x
Yield - - -
Capitalization / Revenue 1.29 x 1.28 x 1.25 x
EV / Revenue 2.16 x 2.07 x 1.92 x
EV / EBITDA 8.4 x 8.01 x 7.35 x
EV / FCF 22.8 x 19.1 x 16.7 x
FCF Yield 4.38% 5.24% 6.01%
Price to Book 2.58 x 2.31 x 1.94 x
Nbr of stocks (in thousands) 1,72,710 - -
Reference price 2 60.45 60.45 60.45
Announcement Date - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2023 2024 2025 2026
Net sales 1 - 8,087 8,187 8,348
EBITDA 1 - 2,077 2,113 2,177
EBIT 1 - 1,765 1,655 1,690
Operating Margin - 21.83% 20.22% 20.25%
Earnings before Tax (EBT) 1 1,667 917 1,008 1,105
Net income 1 1,346 905 920.3 878
Net margin - 11.19% 11.24% 10.52%
EPS 2 - 3.825 3.985 5.090
Free Cash Flow 1 - 764.5 885.5 960.5
FCF margin - 9.45% 10.82% 11.51%
FCF Conversion (EBITDA) - 36.81% 41.91% 44.13%
FCF Conversion (Net income) - 84.48% 96.22% 109.4%
Dividend per Share 2 - - - -
Announcement Date 20/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,016 2,046 2,004 1,999 2,020
EBITDA 1 520 481.2 503.5 434.7 451.7
EBIT 1 484 433.2 456.5 387.7 407.2
Operating Margin 24.01% 21.17% 22.78% 19.4% 20.16%
Earnings before Tax (EBT) - - - - -
Net income 1 - 231 287.6 203.4 235.4
Net margin - 11.29% 14.35% 10.18% 11.65%
EPS 2 - 0.6300 0.9600 0.4700 0.8100
Dividend per Share - - - - -
Announcement Date 09/05/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2023 2024 2025 2026
Net Debt 1 - 7,002 6,473 5,554
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) - 3.371 x 3.064 x 2.552 x
Free Cash Flow 1 - 765 886 961
ROE (net income / shareholders' equity) - 38.2% 23.3% 23%
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 - 23.40 26.20 31.20
Cash Flow per Share 2 - 6.910 6.750 -
Capex 1 - 450 450 450
Capex / Sales - 5.56% 5.5% 5.39%
Announcement Date 20/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
60.45 USD
Average target price
69.67 USD
Spread / Average Target
+15.25%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
SOLVENTUM CORPORATION Stock Solventum Corporation
0.00% 1.04TCr
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+17.74% 8.26TCr
CVS HEALTH CORPORATION Stock CVS Health Corporation
-29.66% 6.99TCr
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
0.00% 2.65TCr
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+3.06% 1.73TCr
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-12.16% 1.66TCr
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.47% 1.56TCr
NATERA, INC. Stock Natera, Inc.
+74.82% 1.32TCr
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+0.76% 1.27TCr
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+73.52% 1.26TCr
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. SOLV Stock
  4. Financials Solventum Corporation